Free Trial

Silexion Therapeutics (SLXN) SEC Filings & 10K Form

$0.24
-0.05 (-17.12%)
(As of 11/1/2024 ET)

Recent Silexion Therapeutics SEC Filings

DateFilerForm TypeView
10/31/2024
4:24 PM
Silexion Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/22/2024
8:02 AM
Silexion Therapeutics (Filer)
Form DEF 14A
10/16/2024
11:15 PM
Silexion Therapeutics (Filer)
Form EFFECT
10/16/2024
8:32 AM
Silexion Therapeutics (Filer)
Form 424B3
10/10/2024
4:00 PM
Silexion Therapeutics (Filer)
Form PRE 14A
10/09/2024
5:04 AM
Silexion Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/01/2024
5:53 AM
Silexion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2024
6:10 AM
Silexion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
3:05 PM
Silexion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
3:06 PM
Silexion Therapeutics (Filer)
Form 424B3
09/18/2024
3:32 PM
Silexion Therapeutics (Filer)
Form 424B3
09/17/2024
11:15 PM
Silexion Therapeutics (Filer)
Form EFFECT
09/09/2024
6:33 PM
Silexion Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
09/09/2024
7:00 AM
Silexion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2024
3:48 PM
Silexion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/22/2024
5:44 PM
Silexion Therapeutics (Subject)
Wildcat Capital Management, LLC (Filed by)
Form SC 13D
08/22/2024
4:23 PM
Moringa Sponsor, LP (Filed by)
Silexion Therapeutics (Subject)
Form SC 13D
08/21/2024
3:45 PM
Silexion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
6:38 PM
Silexion Therapeutics (Issuer)
Lushi Avner (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:43 PM
Abramov Dror Yosef (Reporting)
Silexion Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:47 PM
Silexion Therapeutics (Issuer)
Shiloah Ilan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:48 PM
Silexion Therapeutics (Issuer)
Hadar Ilan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:48 PM
Silexion Therapeutics (Issuer)
Horenshtein Hadar Mirit (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:49 PM
Silexion Therapeutics (Issuer)
Shirvan Mitchell (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:49 PM
Alon Ruth (Reporting)
Silexion Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:50 PM
Silexion Therapeutics (Issuer)
Noy Shlomo (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:54 PM
Silexion Therapeutics (Issuer)
Levin Ilan (Reporting)
Moringa Sponsor, LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
7:12 PM
Silexion Therapeutics (Issuer)
Potter Leonard (Reporting)
Wildcat Capital Management, LLC (Reporting)
Wildcat Partner Holdings, LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
2:22 PM
Silexion Therapeutics (Filer)
Form CERT
08/15/2024
1:45 PM
Silexion Therapeutics (Filer)
Form 8-A12B
07/25/2024
3:05 PM
Silexion Therapeutics (Filed by)
Moringa Acquisition Corp (Subject)
Moringa Acquisition Corp (Subject)
Moringa Acquisition Corp (Subject)
Moringa Acquisition Corp (Subject)
Form 425
07/25/2024
3:05 PM
Silexion Therapeutics (Subject)
Moringa Acquisition Corp (Filed by)
Moringa Acquisition Corp (Filed by)
Moringa Acquisition Corp (Filed by)
Moringa Acquisition Corp (Filed by)
Form 425
07/17/2024
8:06 AM
Silexion Therapeutics (Filer)
Form 424B3
07/16/2024
11:15 PM
Silexion Therapeutics (Filer)
Form EFFECT
07/12/2024
3:21 PM
Silexion Therapeutics (Filer)
Form S-4/A
07/05/2024
2:49 PM
Silexion Therapeutics (Filer)
Form S-4/A
06/24/2024
3:49 PM
Silexion Therapeutics (Filer)
Form S-4/A
05/09/2024
4:18 PM
Silexion Therapeutics (Filer)
Form S-4
Registration statement under Securities Act of 1933  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SLXN) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners